Back to search

Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC).

Y. Bang, E.L. Kwak, Alice T. Shaw, D. Ross Camidge, A. John Iafrate
DOI: 10.1200/jco.2010.28.18_suppl.3
Journal of Clinical Oncology

Data up to Jan 2025

Published2010
Citations138
References0
Fields
MedicineInternal medicineGastroenterologyOncology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with… (2010) – Journal of Clinical Oncology | Metascience Observatory Explorer